Palvella Therapeutics Statistics
Total Valuation
PVLA has a market cap or net worth of $2.16 billion. The enterprise value is $1.95 billion.
Important Dates
The last earnings date was Thursday, November 5, 2026, before market open.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PVLA has 14.62 million shares outstanding. The number of shares has increased by 46.67% in one year.
| Current Share Class | 14.62M |
| Shares Outstanding | 14.62M |
| Shares Change (YoY) | +46.67% |
| Shares Change (QoQ) | +1.22% |
| Owned by Insiders (%) | 7.70% |
| Owned by Institutions (%) | 94.29% |
| Float | 11.01M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 298.16 |
| PB Ratio | 10.76 |
| P/TBV Ratio | 10.78 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 16.01, with a Debt / Equity ratio of 0.13.
| Current Ratio | 16.01 |
| Quick Ratio | 15.87 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.90 |
Financial Efficiency
Return on equity (ROE) is -63.39% and return on invested capital (ROIC) is -31.60%.
| Return on Equity (ROE) | -63.39% |
| Return on Assets (ROA) | -28.68% |
| Return on Invested Capital (ROIC) | -31.60% |
| Return on Capital Employed (ROCE) | -31.31% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.59M |
| Employee Count | 29 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +50.46% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +50.46% |
| 50-Day Moving Average | 142.87 |
| 200-Day Moving Average | 132.10 |
| Relative Strength Index (RSI) | 48.16 |
| Average Volume (20 Days) | 272,540 |
Short Selling Information
The latest short interest is 2.60 million, so 17.80% of the outstanding shares have been sold short.
| Short Interest | 2.60M |
| Short Previous Month | 2.41M |
| Short % of Shares Out | 17.80% |
| Short % of Float | 23.64% |
| Short Ratio (days to cover) | 10.81 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -70.29M |
| Pretax Income | -74.99M |
| Net Income | -74.99M |
| EBITDA | n/a |
| EBIT | -70.29M |
| Earnings Per Share (EPS) | -$5.57 |
Full Income Statement Balance Sheet
The company has $236.68 million in cash and $25.41 million in debt, with a net cash position of $211.27 million or $14.45 per share.
| Cash & Cash Equivalents | 236.68M |
| Total Debt | 25.41M |
| Net Cash | 211.27M |
| Net Cash Per Share | $14.45 |
| Equity (Book Value) | 197.92M |
| Book Value Per Share | 13.55 |
| Working Capital | 224.04M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -43.06M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -43.06M |
| FCF Per Share | -$2.95 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PVLA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -46.67% |
| Shareholder Yield | -46.67% |
| Earnings Yield | -3.77% |
| FCF Yield | -2.02% |
Analyst Forecast
The average price target for PVLA is $233.44, which is 58.17% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $233.44 |
| Price Target Difference | 58.17% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |